Amortization of Intangible Assets in USD of REGENEREX PHARMA, INC. from Q2 2013 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
REGENEREX PHARMA, INC. quarterly/annual Amortization of Intangible Assets history and change rate from Q2 2013 to Q2 2025.
  • REGENEREX PHARMA, INC. Amortization of Intangible Assets for the quarter ending 30 Jun 2025 was $0.000, a 100% decline year-over-year.
  • REGENEREX PHARMA, INC. Amortization of Intangible Assets for the twelve months ending 30 Jun 2025 was $614.000, a 78.6% decline year-over-year.
  • REGENEREX PHARMA, INC. annual Amortization of Intangible Assets for 2024 was $1.33K, a 53.8% decline from 2023.
  • REGENEREX PHARMA, INC. annual Amortization of Intangible Assets for 2023 was $2.88K, a 10.8% decline from 2022.
  • REGENEREX PHARMA, INC. annual Amortization of Intangible Assets for 2022 was $3.22K, a 539% increase from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Change (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Change (%)

REGENEREX PHARMA, INC. Quarterly Amortization of Intangible Assets (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $614 $0 -$714 -100% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $1.33K $1.00 -$713 -99.9% 01 Jan 2025 31 Mar 2025 10-K 30 Jun 2025
Q4 2024 $2.04K $208 -$515 -71.2% 01 Oct 2024 31 Dec 2024 10-Q 07 Feb 2025
Q3 2024 $2.56K $405 -$318 -44% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $2.87K $714 -$1 -0.14% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $2.88K $714 +$374 +110% 01 Jan 2024 31 Mar 2024 10-K 30 Jun 2025
Q4 2023 $2.5K $723 $0 0% 01 Oct 2023 31 Dec 2023 10-Q 07 Feb 2025
Q3 2023 $2.5K $723 $0 0% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024
Q2 2023 $2.5K $715 -$722 -50.2% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $3.22K $340 01 Jan 2023 31 Mar 2023 10-K 24 Jun 2024
Q4 2022 $723 -$293 -28.8% 01 Oct 2022 31 Dec 2022 10-Q 05 Feb 2024
Q3 2022 $723 -$93 -11.4% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2022
Q2 2022 $1.44K +$940 +189% 01 Apr 2022 30 Jun 2022 10-Q 08 Nov 2023
Q4 2021 $1.02K -$1.31K -56.4% 01 Oct 2021 31 Dec 2021 10-Q 24 Jan 2023
Q3 2021 $816 -$498 -37.9% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 $497 -$1.33K -72.8% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q4 2020 $2.33K 01 Oct 2020 31 Dec 2020 10-Q/A 03 Feb 2022
Q3 2020 $1.31K -$2.35K -64.1% 01 Jul 2020 30 Sep 2020 10-Q 01 Nov 2021
Q2 2020 $1.83K +$400 +28% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q3 2019 $5.06K $3.66K +$2.32K +172% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $2.75K $1.43K -$2.59K -64.4% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $5.33K -$1.37K 01 Jan 2019 31 Mar 2019 10-K/A 11 Aug 2020
Q4 2018 $1.34K $0 0% 01 Oct 2018 31 Dec 2018 10-Q 04 Feb 2019
Q3 2018 $1.34K 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2018
Q2 2018 $4.02K +$4.02K 01 Apr 2018 30 Jun 2018 10-Q 10 Feb 2020
Q4 2017 $1.34K 01 Oct 2017 31 Dec 2017 10-Q 04 Feb 2019
Q2 2017 $0 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q3 2014 $833 $0 0% 01 Jun 2014 31 Aug 2014 10-Q 20 Oct 2014
Q2 2014 $834 +$1.00 +0.12% 01 Mar 2014 31 May 2014 10-Q 23 Jul 2014
Q3 2013 $833 01 Jun 2013 31 Aug 2013 10-Q 20 Oct 2014
Q2 2013 $833 01 Mar 2013 31 May 2013 10-Q 23 Jul 2014

REGENEREX PHARMA, INC. Annual Amortization of Intangible Assets (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.33K -$1.55K -53.8% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025
2023 $2.88K -$348 -10.8% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025
2022 $3.22K +$2.72K +539% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024
2021 $504 -$3.66K -87.9% 01 Jan 2021 31 Dec 2021 10-Q/A 03 Feb 2022
2020 $4.17K -$2.82K -40.4% 01 Jan 2020 31 Dec 2020 10-Q/A 03 Feb 2022
2019 $6.99K +$1.66K +31.1% 01 Apr 2019 31 Mar 2020 10-K 23 Jun 2021
2018 $5.33K +$2.68K +101% 01 Apr 2018 31 Mar 2019 10-K/A 11 Aug 2020
2017 $2.66K +$2.66K 01 Apr 2017 31 Mar 2018 10-K 24 Jun 2019
2016 $0 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018
2014 $3.33K -$1 -0.03% 01 Dec 2013 30 Nov 2014 10-K 03 Mar 2015
2013 $3.33K 01 Dec 2012 30 Nov 2013 10-K 03 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.